Search research articles
Contact Us
Filters
Showing results (151-160 of 464) with videos related to
Page
of 47
Sort By:
Journal of Crohn'S & Colitis
|
August 25, 2022
Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
Edward V Loftus, Séverine Vermeire, Brian G Feagan, et al.
The Lancet. Gastroenterology & Hepatology
|
February 4, 2023
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
Brian G Feagan, Bruce E Sands, William J Sandborn, et al.
Gut
|
October 28, 2018
Definitions of response and remission for the Robarts Histopathology Index
Rish K Pai, Reena Khanna, Geert R D'Haens, et al.
Gut
|
October 5, 2014
A phase II study of laquinimod in Crohn's disease
Geert D'Haens, William J Sandborn, Jean Frederic Colombel, et al.
Advances in Therapy
|
March 21, 2025
Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials
Yuki Otani, Brian G Feagan, Geert R D'Haens, et al.
Journal of Crohn'S & Colitis
|
September 30, 2017
The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?
Pieter Hindryckx, Niels Vande Casteele, Gregor Novak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 8, 2020
Development and Validation of a Clinical Decision Support Tool That Incorporates Pharmacokinetic Data to Predict Endoscopic Healing in Patients Treated With Infliximab
Niels Vande Casteele, Vipul Jairath, Jenny Jeyarajah, et al.
Gastroenterology
|
August 19, 2008
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J Sandborn, Brian G Feagan, Richard N Fedorak, et al.
Digestive Diseases and Sciences
|
March 26, 2021
Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review
Christopher Ma, John K MacDonald, Tran M Nguyen, et al.
The American Journal of Gastroenterology
|
November 24, 2011
Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements
Alain Bitton, Donald Buie, Robert Enns, et al.
Page
of 47
Search research articles
Search
Showing results (151-160 of 464) with videos related to
Sort By:
Page
of 47
Journal of Crohn'S & Colitis
|
August 25, 2022
Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
Edward V Loftus, Séverine Vermeire, Brian G Feagan, et al.
The Lancet. Gastroenterology & Hepatology
|
February 4, 2023
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
Brian G Feagan, Bruce E Sands, William J Sandborn, et al.
Gut
|
October 28, 2018
Definitions of response and remission for the Robarts Histopathology Index
Rish K Pai, Reena Khanna, Geert R D'Haens, et al.
Gut
|
October 5, 2014
A phase II study of laquinimod in Crohn's disease
Geert D'Haens, William J Sandborn, Jean Frederic Colombel, et al.
Advances in Therapy
|
March 21, 2025
Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials
Yuki Otani, Brian G Feagan, Geert R D'Haens, et al.
Journal of Crohn'S & Colitis
|
September 30, 2017
The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?
Pieter Hindryckx, Niels Vande Casteele, Gregor Novak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 8, 2020
Development and Validation of a Clinical Decision Support Tool That Incorporates Pharmacokinetic Data to Predict Endoscopic Healing in Patients Treated With Infliximab
Niels Vande Casteele, Vipul Jairath, Jenny Jeyarajah, et al.
Gastroenterology
|
August 19, 2008
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J Sandborn, Brian G Feagan, Richard N Fedorak, et al.
Digestive Diseases and Sciences
|
March 26, 2021
Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review
Christopher Ma, John K MacDonald, Tran M Nguyen, et al.
The American Journal of Gastroenterology
|
November 24, 2011
Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements
Alain Bitton, Donald Buie, Robert Enns, et al.
Page
of 47